Jushi Holdings (JUSHF) Net Income (QoQ) (2021 - 2026)
Jushi Holdings (JUSHF) Net Income (QoQ) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.79 Bn | 86.92 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.11 Bn | 30.17 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.45 Bn | 23.38 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.26 Bn | 21.10 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.21 Bn | 18.41 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Jushi Holdings | 79.29 Mn | 39.58 Mn | 29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.58% |
| Dec 31, 2025 | 34.33% |
| Sep 30, 2025 | -92.11% |
| Jun 30, 2025 | 27.53% |
| Mar 31, 2025 | -36.47% |
| Dec 31, 2024 | 22.15% |
| Sep 30, 2024 | -726.42% |
| Jun 30, 2024 | 89.44% |
| Mar 31, 2024 | -1.95% |
| Dec 31, 2023 | 12.70% |
| Sep 30, 2023 | -46.92% |
| Jun 30, 2023 | -12.83% |
| Mar 31, 2023 | 91.11% |
| Dec 31, 2022 | -155.85% |
| Sep 30, 2022 | -553.31% |
| Jun 30, 2022 | 161.07% |
| Mar 31, 2022 | -418.10% |
| Dec 31, 2021 | -84.35% |
| Sep 30, 2021 | 1,405.39% |